Yanan Wang

2.6k total citations
103 papers, 1.8k citations indexed

About

Yanan Wang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yanan Wang has authored 103 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 27 papers in Cancer Research and 19 papers in Oncology. Recurrent topics in Yanan Wang's work include MicroRNA in disease regulation (17 papers), Antimicrobial Resistance in Staphylococcus (16 papers) and Bacterial biofilms and quorum sensing (13 papers). Yanan Wang is often cited by papers focused on MicroRNA in disease regulation (17 papers), Antimicrobial Resistance in Staphylococcus (16 papers) and Bacterial biofilms and quorum sensing (13 papers). Yanan Wang collaborates with scholars based in China, United States and Romania. Yanan Wang's co-authors include Xiang Li, Tianyu Han, Song Zhang, Sufang Wu, Weichang Chen, Xi Li, Ling Zhang, Wei Bao, Yanli Li and Jiawei Zheng and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Cleaner Production and Scientific Reports.

In The Last Decade

Yanan Wang

97 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanan Wang China 23 967 600 296 185 169 103 1.8k
Hirotaka Takahashi Japan 28 876 0.9× 124 0.2× 202 0.7× 111 0.6× 141 0.8× 133 2.6k
Huili Hu China 23 1.1k 1.1× 301 0.5× 520 1.8× 136 0.7× 81 0.5× 81 2.8k
Eleftherios Vairaktaris Greece 33 731 0.8× 623 1.0× 847 2.9× 198 1.1× 75 0.4× 115 3.0k
Jiaqiang Huang China 25 944 1.0× 218 0.4× 425 1.4× 133 0.7× 76 0.4× 102 2.2k
Yuval Nevo Israel 21 805 0.8× 398 0.7× 155 0.5× 29 0.2× 72 0.4× 54 2.2k
Zhonghan Li United States 23 2.4k 2.5× 1.8k 3.0× 211 0.7× 57 0.3× 192 1.1× 71 3.4k
Xing He China 16 455 0.5× 125 0.2× 679 2.3× 191 1.0× 242 1.4× 35 1.6k
Zhangui Tang China 24 888 0.9× 394 0.7× 253 0.9× 139 0.8× 113 0.7× 94 2.0k
Yi Xiang China 25 602 0.6× 242 0.4× 501 1.7× 522 2.8× 50 0.3× 59 2.0k
Yang Yao China 19 735 0.8× 408 0.7× 224 0.8× 148 0.8× 14 0.1× 45 1.6k

Countries citing papers authored by Yanan Wang

Since Specialization
Citations

This map shows the geographic impact of Yanan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanan Wang more than expected).

Fields of papers citing papers by Yanan Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanan Wang. The network helps show where Yanan Wang may publish in the future.

Co-authorship network of co-authors of Yanan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yanan Wang. A scholar is included among the top collaborators of Yanan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanan Wang. Yanan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yanan, Bo Jin, Qiuling Xie, et al.. (2024). Engineering the orthogonal ubiquitin E1-E2 pairs for identification of K27 chain linkage substrates. International Journal of Biological Macromolecules. 283(Pt 3). 137837–137837.
2.
Zhao, Jing, Yubo Ma, Li‐Bin Pan, et al.. (2023). Chebulagic acid suppresses gastric cancer by inhibiting the AURKA/β-catenin/Wnt pathway. Frontiers in Pharmacology. 14. 1143427–1143427. 6 indexed citations
3.
Zhang, Bing, et al.. (2023). Diabetic and nondiabetic BMSC–derived exosomes affect bone regeneration via regulating miR-17-5p/SMAD7 axis. International Immunopharmacology. 125(Pt B). 111190–111190. 13 indexed citations
4.
Wang, Hao, et al.. (2023). Cisplatin-induced PANDAR-Chemo-EVs contribute to a more aggressive and chemoresistant ovarian cancer phenotype through the SRSF9-SIRT4/SIRT6 axis. Journal of Gynecologic Oncology. 35(2). e13–e13. 8 indexed citations
5.
Wang, Lili, Jin Chen, Na Zhao, et al.. (2023). Commensal Staphylococcus epidermidis Defends against Staphylococcus aureus through SaeRS Two-Component System. ACS Omega. 8(20). 17712–17718. 9 indexed citations
6.
Xiao, Yao, Lujie Ren, Yanan Wang, et al.. (2023). Biochemical Characterization and Functional Analysis of Glucose Regulated Protein 78 from the Silkworm Bombyx mori. International Journal of Molecular Sciences. 24(4). 3964–3964. 2 indexed citations
7.
8.
9.
10.
Li, Qing, Jia Shi, Yi Yang, et al.. (2022). High-Phosphate-Stimulated Macrophage-Derived Exosomes Promote Vascular Calcification via let-7b-5p/TGFBR1 Axis in Chronic Kidney Disease. Cells. 12(1). 161–161. 28 indexed citations
11.
Yang, Wanlin, Jiefang Huang, Miao Xiang, et al.. (2021). Inhibition of Dot1L Alleviates Fulminant Hepatitis Through Myeloid-Derived Suppressor Cells. Cellular and Molecular Gastroenterology and Hepatology. 12(1). 81–98. 3 indexed citations
12.
Chen, Ya, Yanan Wang, Minjuan Hu, et al.. (2021). Pembrolizumab Plus Chemotherapy or Anlotinib vs. Pembrolizumab Alone in Patients With Previously Treated EGFR-Mutant NSCLC. Frontiers in Oncology. 11. 671228–671228. 18 indexed citations
13.
Lü, Huiying, Ying Jian, Yanan Wang, et al.. (2021). The Surge of Hypervirulent ST398 MRSA Lineage With Higher Biofilm-Forming Ability Is a Critical Threat to Clinics. Frontiers in Microbiology. 12. 636788–636788. 15 indexed citations
14.
Zhang, Song, et al.. (2021). The Risks of miRNA Therapeutics: In a Drug Target Perspective. Drug Design Development and Therapy. Volume 15. 721–733. 156 indexed citations
15.
Chen, Ya, Yanan Wang, Minjuan Hu, et al.. (2021). Pembrolizumab Alone or Combined With Chemotherapy in Advanced NSCLC With PD-L1 ≥50%: Results of a Retrospective Study. Frontiers in Oncology. 11. 691519–691519. 7 indexed citations
16.
Wang, Yanan, Qiwei Wang, Bei Wang, et al.. (2020). Inhibition of EZH2 ameliorates bacteria-induced liver injury by repressing RUNX1 in dendritic cells. Cell Death and Disease. 11(11). 1024–1024. 15 indexed citations
17.
Zhou, Rong, Chaoji Shi, Jiang Li, et al.. (2019). Analysis of Mucosal Melanoma Whole-Genome Landscapes Reveals Clinically Relevant Genomic Aberrations. Clinical Cancer Research. 25(12). 3548–3560. 64 indexed citations
18.
Wang, Yanan, et al.. (2017). microRNA-1297 Inhibits the Growth and Metastasis of Colorectal Cancer by Suppressing Cyclin D2 Expression. DNA and Cell Biology. 36(11). 991–999. 30 indexed citations
19.
Zou, Shasha, Yanan Wang, Tingting Chen, et al.. (2014). Ectopic expression of Sonic Hedgehog in a cryptorchid man with azoospermia: A case report. Journal of International Medical Research. 42(2). 589–597. 3 indexed citations
20.
Wang, Yanan & Jianbo Su. (2013). Symmetry description and face recognition using face symmetry based on local binary pattern feature. Chinese Control Conference. 3955–3960. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hirotaka Takahashi Breakdown of academic impact, for papers by Huili Hu Breakdown of academic impact, for papers by Eleftherios Vairaktaris Breakdown of academic impact, for papers by Jiaqiang Huang Breakdown of academic impact, for papers by Yuval Nevo Breakdown of academic impact, for papers by Zhonghan Li Breakdown of academic impact, for papers by Xing He Breakdown of academic impact, for papers by Zhangui Tang Breakdown of academic impact, for papers by Yi Xiang Breakdown of academic impact, for papers by Yang Yao
Rankless by CCL
2026